Epstein Barr virus nRNA (Lakewood Amedex)

N/A

Report date: 2022/01/28 17:06:21

NME

Base Information

Drug NameEpstein Barr virus nRNA (Lakewood Amedex)

Drug Alias NameEBV nRNAEBV nanoRNAEBV-nRNA - Lakewood-Amedex

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionVirus replication inhibitorsRNA interference

TargetsUpdating

Therapy Area/IndicationsNasopharyngeal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLakewood-Amedex Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNasopharyngeal Neoplasms

ATC CodeN/A